InflaRx
IFRX
34 hedge funds and large institutions have $482M invested in InflaRx in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 11 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more capital invested
Capital invested by funds: $459M → $482M (+$22.6M)
1.79% less ownership
Funds ownership: 52.84% → 51.05% (-1.8%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
11% less funds holding
Funds holding: 38 → 34 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.11M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.97M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.61M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.62M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$1.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$7.04M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.58M |
| 3 |
BlackRock
New York
|
-$3.53M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.26M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.59M |
IFRX Hedge Fund Activity: Q4 2018 in Review
34 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2018, worth a combined $482M — up 4.9% from $459M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IFRX and 7 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Cormorant Asset Management, adding an estimated $4.11M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $7.04M sold.
- 34 institutional investors held InflaRx (IFRX) as of Q4 2018, down from 38 in Q3 2018.
- Funds reported $482M of InflaRx stock for Q4 2018, up 4.9% quarter-over-quarter.
- 7 funds opened new InflaRx positions in Q4 2018 and 11 closed out, a net change of -4 holders.
- The largest InflaRx buyer in Q4 2018 was Cormorant Asset Management, an estimated $4.11M added.
- The largest InflaRx seller in Q4 2018 was Scopia Capital Management, an estimated $7.04M sold.
Based on aggregated 13F filings for Q4 2018.